Barriers to initiation of antiretrovirals during antituberculosis therapy in Africa
dc.contributor.author | Pepper, Dominique J | en_ZA |
dc.contributor.author | Marais, Suzaan | en_ZA |
dc.contributor.author | Wilkinson, Robert J | en_ZA |
dc.contributor.author | Bhaijee, Feriyl | en_ZA |
dc.contributor.author | De Azevedo, Virginia | en_ZA |
dc.contributor.author | Meintjes, Graeme | en_ZA |
dc.date.accessioned | 2015-12-28T06:47:46Z | |
dc.date.available | 2015-12-28T06:47:46Z | |
dc.date.issued | 2011 | en_ZA |
dc.description.abstract | BACKGROUND: In the developing world, the principal cause of death among HIV-infected patients is tuberculosis (TB). The initiation of antiretroviral therapy (ART) during TB therapy significantly improves survival, however it is not known which barriers prevent eligible TB patients from initiating life-saving ART. Method Setting. A South African township clinic with integrated tuberculosis and HIV services. Design. Logistic regression analyses of a prospective cohort of HIV-1 infected adults (≥18 years) who commenced TB therapy, were eligible for ART, and were followed for 6 months. FINDINGS: Of 100 HIV-1 infected adults eligible for ART during TB therapy, 90 TB patients presented to an ART clinic for assessment, 66 TB patients initiated ART, and 15 TB patients died. 34% of eligible TB patients (95%CI: 25-43%) did not initiate ART. Male gender and younger age (<36 years) were associated with failure to initiate ART (adjusted odds ratios of 3.7 [95%CI: 1.25-10.95] and 3.3 [95%CI: 1.12-9.69], respectively). Death during TB therapy was associated with a CD4+ count <100 cells/µL. CONCLUSION: In a clinic with integrated services for tuberculosis and HIV, one-third of eligible TB patients - particularly young men - did not initiate ART. Strategies are needed to promote ART initiation during TB therapy, especially among young men. | en_ZA |
dc.identifier.apacitation | Pepper, D. J., Marais, S., Wilkinson, R. J., Bhaijee, F., De Azevedo, V., & Meintjes, G. (2011). Barriers to initiation of antiretrovirals during antituberculosis therapy in Africa. <i>PLoS One</i>, http://hdl.handle.net/11427/16050 | en_ZA |
dc.identifier.chicagocitation | Pepper, Dominique J, Suzaan Marais, Robert J Wilkinson, Feriyl Bhaijee, Virginia De Azevedo, and Graeme Meintjes "Barriers to initiation of antiretrovirals during antituberculosis therapy in Africa." <i>PLoS One</i> (2011) http://hdl.handle.net/11427/16050 | en_ZA |
dc.identifier.citation | Pepper, D. J., Marais, S., Wilkinson, R. J., Bhaijee, F., De Azevedo, V., & Meintjes, G. (2011). Barriers to initiation of antiretrovirals during antituberculosis therapy in Africa. PLoS ONE, 6(5), e19484. doi:10.1371/journal.pone.0019484 | en_ZA |
dc.identifier.ris | TY - Journal Article AU - Pepper, Dominique J AU - Marais, Suzaan AU - Wilkinson, Robert J AU - Bhaijee, Feriyl AU - De Azevedo, Virginia AU - Meintjes, Graeme AB - BACKGROUND: In the developing world, the principal cause of death among HIV-infected patients is tuberculosis (TB). The initiation of antiretroviral therapy (ART) during TB therapy significantly improves survival, however it is not known which barriers prevent eligible TB patients from initiating life-saving ART. Method Setting. A South African township clinic with integrated tuberculosis and HIV services. Design. Logistic regression analyses of a prospective cohort of HIV-1 infected adults (≥18 years) who commenced TB therapy, were eligible for ART, and were followed for 6 months. FINDINGS: Of 100 HIV-1 infected adults eligible for ART during TB therapy, 90 TB patients presented to an ART clinic for assessment, 66 TB patients initiated ART, and 15 TB patients died. 34% of eligible TB patients (95%CI: 25-43%) did not initiate ART. Male gender and younger age (<36 years) were associated with failure to initiate ART (adjusted odds ratios of 3.7 [95%CI: 1.25-10.95] and 3.3 [95%CI: 1.12-9.69], respectively). Death during TB therapy was associated with a CD4+ count <100 cells/µL. CONCLUSION: In a clinic with integrated services for tuberculosis and HIV, one-third of eligible TB patients - particularly young men - did not initiate ART. Strategies are needed to promote ART initiation during TB therapy, especially among young men. DA - 2011 DB - OpenUCT DO - 10.1371/journal.pone.0019484 DP - University of Cape Town J1 - PLoS One LK - https://open.uct.ac.za PB - University of Cape Town PY - 2011 T1 - Barriers to initiation of antiretrovirals during antituberculosis therapy in Africa TI - Barriers to initiation of antiretrovirals during antituberculosis therapy in Africa UR - http://hdl.handle.net/11427/16050 ER - | en_ZA |
dc.identifier.uri | http://hdl.handle.net/11427/16050 | |
dc.identifier.uri | http://dx.doi.org/10.1371/journal.pone.0019484 | |
dc.identifier.vancouvercitation | Pepper DJ, Marais S, Wilkinson RJ, Bhaijee F, De Azevedo V, Meintjes G. Barriers to initiation of antiretrovirals during antituberculosis therapy in Africa. PLoS One. 2011; http://hdl.handle.net/11427/16050. | en_ZA |
dc.language.iso | eng | en_ZA |
dc.publisher | Public Library of Science | en_ZA |
dc.publisher.department | Institute of Infectious Disease and Molecular Medicine | en_ZA |
dc.publisher.faculty | Faculty of Health Sciences | en_ZA |
dc.publisher.institution | University of Cape Town | |
dc.rights | credited. | en_ZA |
dc.rights.holder | © 2011 Pepper et al | en_ZA |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0 | en_ZA |
dc.source | PLoS One | en_ZA |
dc.source.uri | http://journals.plos.org/plosone | en_ZA |
dc.subject.other | Tuberculosis | en_ZA |
dc.subject.other | Antiretroviral therapy | en_ZA |
dc.subject.other | Tuberculosis diagnosis and management | en_ZA |
dc.subject.other | Mycobacterium tuberculosis | en_ZA |
dc.subject.other | History of tuberculosis | en_ZA |
dc.subject.other | HIV diagnosis and management | en_ZA |
dc.subject.other | Drug screening | en_ZA |
dc.subject.other | Hospitals | en_ZA |
dc.title | Barriers to initiation of antiretrovirals during antituberculosis therapy in Africa | en_ZA |
dc.type | Journal Article | en_ZA |
uct.type.filetype | Text | |
uct.type.filetype | Image | |
uct.type.publication | Research | en_ZA |
uct.type.resource | Article | en_ZA |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Pepper_Barriers_to_Initiation_of_Antiretrovirals_2011.pdf
- Size:
- 188.61 KB
- Format:
- Adobe Portable Document Format
- Description: